Oct 03, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2025 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq: BCRX ) today announced that the compensation committee of BioCryst's board of directors granted eight newly-hired employees stock options to purchase an aggregate of 115,000 shares, and ...
Oct 01, 2025 • Benzinga
NEUTRAL
BioCryst Completes Sale of European ORLADEYO® ( berotralstat ) Business - BioCryst Pharma ( NASDAQ:BCRX )
RESEARCH TRIANGLE PARK, N.C., Oct. 01, 2025 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) today announced that it has successfully completed the previously announced sale of its European ORLADEYO business to Neopharmed Gentili.
Oct 01, 2025 • GlobeNewswire
NEUTRAL
BioCryst Completes Sale of European ORLADEYO® ( berotralstat ) Business
- Transaction valued at $250 million, with up to $14 million in future milestones ...
Sep 03, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq: BCRX ) today announced that the compensation committee of BioCryst's board of directors granted nine newly-hired employees stock options to purchase an aggregate of 36,700 shares, and ...
Aug 21, 2025 • Benzinga
NEUTRAL
Why Is Ionis Pharma Stock Gaining Thursday? - Ionis Pharmaceuticals ( NASDAQ:IONS )
Dawnzera cut monthly HAE attacks by 81% vs placebo in Phase 3, with up to 87% reduction after second dose. Patients switching from Takhzyro or Orladeyo saw a 62% lower HAE attack rate with Dawnzera. See the 6X seasonal strategy set to target this fall's biggest opportunities. Details here →
Aug 21, 2025 • Benzinga
SOMEWHAT-BULLISH
BioCryst to Present at Upcoming Investor Conference - BioCryst Pharma ( NASDAQ:BCRX )
RESEARCH TRIANGLE PARK, N.C., Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. BCRX today announced that the company plans to present at the Cantor Global Healthcare Conference in New York on Thursday, September 4, 2025, at 9:45 a.m. ET.